Trials / Unknown
UnknownNCT03457298
Lateral Ridge Augmentation Using a Volume Maintaining Collagen Scaffold Versus Allograft With Collagen Membrane.
Lateral Ridge Augmentation Using a Volume Maintaining Collagen Scaffold (Ossix Volumax) Versus Freeze-dried Bone Allograft (FDBA) With Collagen Membrane
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The aim of the current study is to compare lateral bone augmentation using the current gold standard (FDBA plus resorbable collagen membrane) versus Ossix Volumax as a stand-alone material.
Detailed description
One of the major problems in implant therapy is the need to regenerate bone after its resorption because of periodontal disease, traumatic extraction or surgical removal associated with treatment of invasive lesions. Ossix Volumax is a novel volume maintaining collagen scaffold designed for bone augmentation in the atrophic ridge. It is 1-2 mm in thickness and undergoes mineralization progressing into ossification. Thirty subjects requiring lateral bone augmentation of the maxilla or the mandible will be recruited study: Of these, twenty will be recruited and treated at the School of Dental Medicine, Harvard University, Boston, USA and ten (10) at the School of Graduate Dentistry, Rambam health care campus, Haifa, Israel. Hypothesis: The use of Ossix Volumax as a stand-alone augmentation material will results similar increase in the ridge width and volume compared to FDBA and barrier membrane when coupled together.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ossix Volumax | Ossix Volumax is intended to be used for Lateral ridge augmentation |
| DEVICE | FDBA with collagen membrane | freeze-dried bone allograft (FDBA) with collagen membrane |
Timeline
- Start date
- 2018-11-07
- Primary completion
- 2020-04-01
- Completion
- 2020-07-01
- First posted
- 2018-03-07
- Last updated
- 2019-05-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03457298. Inclusion in this directory is not an endorsement.